Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hepatitis C treatment by non-specialists versus specialists in the Brazilian public health system
RBR-4qmypqqPhase 4Not yet recruiting
- Sponsor
- Fundação Oswaldo Cruz
- Start
- Dec 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sofosbuvir and velpatasvir in hepatitis C virus infection (2 arms), sponsored by Fundação Oswaldo Cruz. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
sofosbuvirvelpatasvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on RBR-4qmypqq.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4qmypqq.